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FAbstract
There is increasing recognition that reinfection is an important component of TB transmission. Moreover, it has been shown that
partial immunity has signiﬁcant epidemiological consequences, particularly in what concerns disease prevalence and effectiveness of
control measures. We address the problem of drug resistance as a competition between two types of strains of Mycobacterium
tuberculosis: those that are sensitive to anti-tuberculosis drugs and those that are resistant. Our objective is to characterise the role of
reinfection in the transmission of drug-resistant tuberculosis. The long-term behaviour of our model reﬂects how reinfection modiﬁes the
conditions for coexistence of sensitive and resistant strains. This sets the scene for discussing how strain prevalence is affected by different
control strategies. It is shown that intervention effectiveness is highly sensitive to the baseline epidemiological setting.
r 2006 Elsevier Inc. All rights reserved.
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T1. Introduction
Tuberculosis (TB) is a disease caused by infection with
Mycobacterium tuberculosis, which most frequently affects
the lungs (pulmonary TB). It is one of the most common
infectious diseases with two billion people (one-third of the
world’s population) currently infected. Nine million new
cases of active disease develop each year, resulting in two
million deaths, mostly in developing countries. Despite
intensive control efforts, recent data show that global
incidence is increasing, largely due to an association with
human immunodeﬁciency virus (HIV) (World Health
Organization, 2005). Treatment efﬁcacy is decreasing due
to the emergence of multi-drug resistant strains (Dye et al.,
2002).
According to a recent report of the World Health
Organization (WHO) (WHO/IUATLD, 2004), the overall
prevalence of drug resistance ranges from 0% (Andorra,77
79
81
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tpb.2006.10.004Iceland and Malta) to 63.9% (Karakalpakstan, Uzebeki-
stan) with a median of 10.4%. The WHO distinguishes
between two types of resistance: acquired resistance—
resistance among previously treated patients; and primary
resistance—resistance among new cases (WHO/IUATLD,
1998). In all regions studied, prevalence of acquired
resistance is higher than prevalence of primary resistance,
but the size of this difference varies between regions (WHO/
IUATLD, 2004).
Treatment of TB consists of a combination of different
drugs to avoid acquisition of resistance. Despite these
precautions, drug resistance continues to emerge being
favoured by the long duration of treatment and improper
use of the antibiotics (Crofton et al., 1997). Drug resistant
TB has higher rates of treatment failure and longer periods
of infectiousness in part due to the time lapse between TB
diagnosis and obtaining drug-sensitivity test results (Esp-
inal et al., 2000). Most worrisome is resistance to the two
ﬁrst line drugs, isoniazid and rifampicin, deﬁned as multi-
drug resistance (MDR). Geographical distribution of MDR
is very heterogeneous: it is highly prevalent in several areas
of the former Soviet Union and in Israel, Ecuador and
some Provinces of China, but it is absent or present with83
rculosis—a reinfection model. Theoretical Population Biology (2006),
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Fig. 1. TB model.
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very low prevalence in a signiﬁcant number of countries.
Prevalence of MDR TB ranges from 0% to 26.8%, with a
median of 1.7% (WHO/IUATLD, 2004).
Mathematical models have addressed the transmission
dynamics of antibiotic resistance in general (Austin et al.,
1997; Bonhoeffer, 2002; Boni and Feldman, 2005). More
speciﬁcally to TB, a number of mathematical models have
also been proposed (Blower and Chou, 2004; Blower and
Gerberding, 1998; Blower et al., 1996; Castillo-Chavez and
Feng, 1997; Cohen and Murray, 2004; Dye and Espinal,
2001; Dye and Williams, 2000). Overall these models
assume that resistant strains are less transmissible, reﬂect-
ing a trade-off between ﬁtness and resistance. Combined
results demonstrate that the relative ﬁtness between
resistant and sensitive strains is a crucial parameter: for
some values it is predicted that second-line drugs would be
needed to prevent future epidemics (Dye and Espinal,
2001), whereas for other values it appears as a local
problem that can be managed through proper implementa-
tion of strategies currently recommended by the WHO (Dye
and Williams, 2000). Moreover, Cohen and Murray (2004)
ﬁnd that even when resistant strains have, on average, a
lower transmissibility a small subpopulation of a relatively
ﬁt MDR strain may outcompete both the drug-sensitive
strains and the less ﬁt MDR strains. Therelation between
resistance acquisition and ﬁtness cost as well as its
epidemiological consequences in M. tuberculosis is, how-
ever, under discussion (Cohen et al., 2003; Gagneux et al.,
2006).
Although it is recognised that reinfection is an important
component of TB transmission (Chiang and Riley, 2005),
few modellers take it into consideration. It has been shown
that for infectious diseases where immunity acquired by
individuals after exposure is not totally protective, allowing
for reinfection to occur at a reduced rate, the equilibrium
prevalence of infection is highly sensitive to a threshold
other than the epidemic threshold. This has been named the
‘reinfection threshold’ and marks a critical transmission
rate above which reinfection processes are dominant
(Gomes et al., 2004, 2005a,b; Breban and Blower, 2005).
The reinfection threshold has strong implications on
epidemiological reasoning, particularly in what respects
the effectiveness of interventions.
For the case of resistant TB, a few models have
considered reinfection (Blower and Chou, 2004; Castillo-
Chavez and Feng, 1997; Cohen and Murray, 2004; Dye and
Williams, 2000) but the implementations vary signiﬁcantly.
Blower and Chou (2004) and Dye and Williams (2000)
incorporate reinfection at a reduced rate (partial immunity)
applying to latent individuals only. Blower and Chou
(2004) assume that recovered individuals have either total
protection against reinfection (if treated), or no protection
at all (if self-cured). By contrast, Dye and Williams (2000)
assume that self-cured individuals have a high relapse but
cannot be reinfected. Castillo-Chavez and Feng (1997)
neglect exogenous reinfection of latent individuals and
assume superinfection but only by resistant strains. CohenPlease cite this article as: Rodrigues, P., et al., Drug resistance in tube
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and Murray (2004) consider that latent and recovered
individuals beneﬁt from partial immunity and have
identical susceptibilities to reinfection. Reinfection can
happen with different strains and the new strain always
replaces the previous one. The model characterises strains
by both ﬁtness and resistance status reaching a level of
complexity that limits its analysis in what reinfection is
concerned.
We extend previous work by devoting special care to the
implementation of reinfection and analysis of its conse-
quences to the spread of drug-resistant TB. The model is
based on a reinfection framework for the transmission of
TB (Gomes et al., 2004), and extended to describe the
competition between two types of strains: sensitive and
resistant to drugs. Model extension is made in steps
permitting intermediate analysis in a systematic way. We
describe how coexistence is shaped by reinfection dynamics
and by the outcome of mixed infection. The model predicts
that coexistence is common for highly endemic settings due
to the greater relative importance of reinfection. Long-term
effectiveness of different control measures is considered,
and shows important sensitivity to the baseline epidemio-
logical setting.ED
 PR2. Model construction
2.1. Exogenous reinfection and endogenous reactivation
The model is based on the TB transmission framework
proposed in Gomes et al. (2004). The host population is
divided into different categories based on the individual
history of infection. Three classes characterise the host
population: susceptible (S), who have never been exposed
to the mycobacterium; latent (L), who are infected but not
infectious; and infectious (I) with active disease (see the
diagram in Fig. 1). Population size is assumed constant
over time. Susceptible individuals are infected at a rate
proportional to the prevalence of active TB and may
develop active disease (progress to I) or maintain a latent
infection (enter L). Individuals who recover from active
disease by treatment with antibiotics or self-cure are
transferred from I back to L. Infected individuals acquire
some immunity as a result of infection, which reduces the
risk of subsequent infection but does not fully prevent it.rculosis—a reinfection model. Theoretical Population Biology (2006),
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Fig. 2. Equilibrium curve: heavy black line represents all TB cases. Thin
dashed and full lines represent primary and reinfection cases, respectively.
Vertical line marks the reinfection threshold.
Fig. 3. Two-strain TB model.
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Finally, latent individuals can progress to active TB due to
endogenous reactivation or exogenous reinfection.
Fig. 2 shows the equilibrium curve for the proportion of
active infections and illustrates the reinfection threshold
(Gomes et al., 2004). Above this threshold most TB cases
are due to reinfection. Thinner lines in this ﬁgure trace the
equilibrium proportion of cases resulting from primary
infection and reinfection, respectively.
2.2. Drug resistance
The model is extended to include two strains with
different sensitivities to antibiotics (see diagram in Fig. 3).
We specify drug-resistant and drug-sensitive strains by
adding subscripts r and s to model variables and
parameters.
Resistant cases may emerge when individuals are infected
with a resistant strain (primary resistance) or as a result of
treatment failure (acquired resistance). We assume that a
fraction, g, of infectious individuals with active sensitive TB
ðIsÞ progresses into the infectious class of resistant strains
ðIrÞ due to treatment failure. These correspond to cases of
acquired resistance.
2.3. Strain interactions
Molecular epidemiological studies suggest that mixed
infections (infections with more than one strain) are
common (Warren et al., 2004), and that once an individual
is infected with both sensitive and resistant strains, a
differential selection pressure will be imposed by treatment
(van Rie et al., 2004). Moreover, an individual infected withPlease cite this article as: Rodrigues, P., et al., Drug resistance in tube
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Oboth resistant and sensitive strains may have two alter-
native progressions: (i) develop resistant TB if treated with
the drugs to which one of the strains is resistant; or (ii)
develop sensitive TB if untreated or if treated with a
regimen set as to overcome the speciﬁc resistance pattern.
Initially we assume that when an individual is infected
with both resistant and sensitive strains there will be a
preferential activation (and transmission) of resistant
strains—scenario (i) above. This corresponds to a worse
case scenario where the treatment regimen available is not
totally effective and selects for resistance. Later, in Section
5, we show that the results essentially extend to a more
general implementation of mixed infection—scenario (ii)
above.
The two-strain model can be represented as the system of
differential equations:
dS
dt
¼ b ðbsI s þ brI r þ mÞS;
dLs
dt
¼ ð1 fÞbsI sS  ðoþ fsbsI s þ sbrI r þ mÞLs
þð1 gÞtsI s;
dLr
dt
¼ ð1 fÞbrI rS þ ð1 fÞsbrI rLs
ðoþ fsbsI s þ fsbrI r þ mÞLr þ trI r;
dIs
dt
¼ fbsI sS þ ðoþ fsbsI sÞLs  ðts þ mþ dÞIs;
dIr
dt
¼ fbrI rS þ fsbrI rLs þ ðoþ fsbsI s þ fsbrI rÞLr
þ gtsI s  ðtr þ mþ dÞI r:
8>>>>>>>>>>>><
>>>>>>>>>>>>:
(1)
Parameter values are given and described in Table 1.
Parameters that refer to sensitive TB take values as in
Gomes et al. (2004). Reactivation rate is considered the
same for sensitive and resistant infections. Individuals
reactivate at a low rate so that a majority never progress torculosis—a reinfection model. Theoretical Population Biology (2006),
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Table 1
Two-strain model parameters
Symbol Deﬁnition Value
bs;br Transmission coefﬁcient Variable
m Death rate and birth rate 1=70 yr1
d Death rate associated to TB 0:2 yr1
f Proportion of individuals that develop active TB 0.1
(the remaining 1 f have latent sensitive TB)
s Factor reducing the risk of infection as a result of acquired 0.25
immunity to a previous infection with sensitive and resistant TB
o Rate of endogenous reactivation of latent TB 0:0002 yr1
ts; tr Rate of treatment of active sensitive and resistant TB 2; 1:5 yr1
g Proportion of sensitive TB treatment failure acquiring resistance 0.003 (or g ¼ 0)
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active disease (Gomes et al., 2004; Vynnycky and Fine,
1997). Different assumptions can be found in the literature
that discriminate related mechanisms such as relapse of self-
cured individuals or of treated patients, chronic infections
and successive treatment failures (Blower and Chou, 2004;
Dye et al., 1998; Castillo-Chavez and Feng, 1997; Dye and
Williams, 2000, respectively). We assume the rate of
mortality associated to TB as in Dye and Espinal (2001).
Birth rate b compensates for disease-induced and back-
ground mortality to keep the population size constant over
time, so b ¼ mþ dðIs þ IrÞ. The proportion acquiring
resistance, g, is on the lower bound of ranges considered
in Cohen and Murray (2004) and Dye and Espinal (2001).
We assume that the period of infectiousness of a resistant
TB case is, on average, two months longer than that of a
sensitive case. There is evidence that an individual infected
with a resistant strain stays longer in the infectious state due
to either improper regimen, late identiﬁcation of the
resistance phenotype, or lower efﬁcacy of treatment
(Espinal et al., 2000). The factor reducing the risk of
infection as a result of acquiring immunity, s, is the same
for both resistant and sensitive strains. Differences in
transmission rates are explored by continuously varying the
strain-speciﬁc transmission coefﬁcients bs and br.
3. Equilibria and stability
For system (1) the simplex
S :¼ fðS;Ls;Lr; Is; IrÞ 2 ðRþ0 Þ5 : S þ Ls þ Lr þ Is þ Ir ¼ 1g
is a positively invariant set, and thus we restrict the study of
the solutions of the system to S. By the fundamental theory
of ODE’s, we know that (1) deﬁnes a dynamical system on
S as uniqueness, global existence and continuous depen-
dence of solutions on initial data is guaranteed when initial
values are in S.
3.1. Basic reproduction number, R0
We calculate the basic reproduction number, R0, using
the next generation approach, developed in van denPlease cite this article as: Rodrigues, P., et al., Drug resistance in tube
doi:10.1016/j.tpb.2006.10.004ED
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Driessche and Watmough (2002). The basic reproduction
number is deﬁned as the dominant eigenvalue of the next
generation matrix,
R0 ¼ maxfR0s;R0rg,
where R0s and R0r are the two eigenvalues (see Appendix
A.1 for details):
R0s ¼ bsðoþ fmÞðmþ oÞðmþ dþ tsÞ  ð1 gÞtso
,
R0r ¼
brðoþ fmÞ
ðmþ oÞðmþ dþ trÞ  otr
. ð2Þ
We can also interpret R0s and R0r as the average number of
secondary infectious cases that an infectious individual
(with a sensitive or a resistant strain, respectively) would
generate in a totally susceptible host population. A thresh-
old condition for endemicity is given by R0 ¼ 1: the disease
dies out if R0o1, and becomes endemic if R041.
3.2. Steady states
System (1) has one disease-free equilibrium, E0 ¼
ð1; 0; 0; 0; 0Þ and two endemic equilibria of the form Er ¼
ðSr; 0;Lrr; 0; IrrÞ and Ers ¼ ðS;Ls ;Lr ; Is ; Ir Þ, corresponding,
respectively, to states where only resistant strains, or both
types of strains are present.
The bifurcation diagram in Fig. 4(a) divides the
ðR0s;R0rÞ-space into three regions as characterised by the
long-term epidemiological outcomes, each corresponding to
a stable steady state of the system: disease eradication (I),
persistence of only drug-resistant TB (II) or coexistence i.e.,
persistence of both drug-sensitive and drug-resistant TB
(III).
Note that, infectious cases with sensitive strains give rise
to new cases of resistant strains at a constant rate g40, due
the acquisition of resistance through treatment failure. It is,
therefore, not possible to have an equilibrium where only
sensitive strains are present. However, this equilibrium
exists in the limit g ¼ 0, which corresponds to no acquired
resistance. The resulting equilibrium has the form Es ¼
ðSs;Lss; 0; Iss; 0Þ and in Fig. 4(b) we can see the correspond-
ing stability region (marked as IV). We explore this limitrculosis—a reinfection model. Theoretical Population Biology (2006),
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Fig. 4. Long-term epidemiological outcome: (a) g40; (b) g ¼ 0. I—disease eradication; II—persistence drug-resistant TB only; III—coexistence. IV—
persistence drug-sensitive TB only. The dotted line corresponds to the model without reinfection s ¼ 0.
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case in more detail in Section 3.5, but otherwise we consider
g40.
3.3. Stability of the disease-free equilibrium
The stability properties of the disease-free equilibrium
(trivial equilibrium) E0, corresponding to the threshold
condition for endemicity are given by Theorem 1, stated
below and proved in Appendix A.2.
Theorem 1. The disease-free equilibrium E0 of system (1) is
locally asymptotically stable, if R0o1, i.e., if R0so1 and
R0ro1, and it is unstable for R041.
Remark 1. Numerical results suggest that the disease-free
equilibrium is in fact globally asymptotically stable for
R0o1.
3.4. Stability of boundary and coexistence equilibria
The existence of an equilibrium for which only resistant
strains persist is given by Theorem 2, stated below and
proved in Appendix A.3.
Theorem 2. System (1) has exactly one non-trivial boundary
equilibrium, Er ¼ ðSr; 0;Lrr; 0; IrrÞ, for R0r41.
In order to derive an expression for the region of stability
of the boundary equilibrium we measure the capacity of
sensitive TB strains to invade and persist in a population
where resistant TB is at equilibrium. In this context, Er ¼
ðSr; 0;Lrr; 0; IrrÞ corresponds to an equilibrium free of
sensitive TB. Applying the methods in van den Driessche
and Watmough (2002) once again we ﬁnd the basic
reproduction number of the sensitive strains in a population
where resistant strains are ﬁxed (see Appendix A.3 for
details):
R0sðErÞ ¼
Srbsðfðmþ sbrI rrÞ þ oÞ
ðmþ sbrI rr þ oÞðmþ dþ tsÞ  ð1 gÞtso
.Please cite this article as: Rodrigues, P., et al., Drug resistance in tube
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OFThis formalism permits the derivation of a thresholdcondition for coexistence, now equivalent to a threshold
condition for sensitive TB endemicity in a population where
resistant strains are at equilibrium, R0sðErÞ ¼ 1: only
resistant TB persists for R0sðErÞo1, while for R0sðErÞ41
sensitive strains can invade a population where resistant
strains are ﬁxed, that is, to say coexistence is possible.
Theorem 3 below expresses this result in terms of stability
for the equilibrium Er. The proof is in Appendix A.3.
Theorem 3. If R0r41 the equilibrium Er of system (1) is
stable for R0sðErÞo1 and unstable for R0sðErÞ41.
Remark 2. The curve that deﬁnes the coexistence region is
given by the following relation (see Fig. 4):
R0sðErÞ ¼ 1()bs ¼ f ðbrÞ
¼ ðmþ sbrI
r
rÞðmþ dþ tsÞ þ oðmþ dþ gtsÞ
Srðfðmþ sbrI rrÞ þ oÞ
. ð3Þ
Remark 3. Numerical results support that below the curve
deﬁned by f in the ðR0s;R0rÞ-space both types of strains will
persist.
Relation (3) reveals that persistence of sensitive strains
depends on the reinfection process. The expression of
R0sðErÞ is similar to that for R0s in (2) with an additional
term, sbrI
r
r. This term corresponds to reinfection by
resistant strains of latent individuals infected with sensitive
TB. Contrasting with the case where reinfection is not
considered, s ¼ 0 (dotted line in Fig. 4), reveals that
persistence of only resistant strains is now possible even
when these have lower transmissibility R0roR0s. Coex-
istence is no longer governed solely by the invasion
capacities of each strain (R0s and R0r) but also by the
ability of sensitive strains to overcome the reinfection
pressure exerted by resistant strains. In particular, our
results can be compared to the analysis of Blower and
Gerberding (1998) (see Fig. 2 and Table 1 within), which
does not consider reinfection. The model developed byrculosis—a reinfection model. Theoretical Population Biology (2006),
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these authors has the same possible outcomes (I,II,III) but
these are fully determined by a linear relation between
pathogen ﬁtness as measured by the respective R0: disease
eradication (I) if R0so1 and R0ro1; persistence of only
resistant TB (II) if R0r41 and R0r4R0s; of both drug
sensitive and drug-resistant TB (III) if R0s41 and R0s4R0r.
3.5. Limit case: g ¼ 0
The limit case g ¼ 0 is equivalent to assuming that there
is no acquisition of drug resistance through treatment
failure. Analysis of this limit case reveals regions where the
elimination of drug-resistant strains may result from
prevention of acquired resistance alone.
For g ¼ 0, the system has three non-trivial equilibria
corresponding to the presence of each type of strains alone
and coexistence (Fig. 4(b)). The existence of the ﬁrst two is
given by Theorem 4, stated below and proved in Appendix
A.4.
Theorem 4. For g ¼ 0, system (1) has exactly two non-trivial
boundary equilibria: Er ¼ ðSr; 0;Lrr; 0; IrrÞ for R0r41 and
Es ¼ ðSs;Lss; 0; Iss; 0Þ for R0s41.
Two coexistence thresholds must be calculated: the ﬁrst
separates the region where only sensitive TB persists from
the region of coexistence; the second marks the shift from
coexistence to persistence of resistant TB alone.
Regarding the second threshold, it can be veriﬁed that
the threshold condition is the same as when g40, i.e.,
R0sðErÞ ¼ 1. Moreover, the stability results pertaining the
equilibrium Esr (Theorem 3) can be extended to the case
g ¼ 0. To compute the ﬁrst threshold we use the same
reasoning as before. We consider resistant TB as the
phenotype invading a population where sensitive TB is
already endemic. Then, Es ¼ ðSs;Lss; 0; Iss; 0Þ corresponds to
the equilibrium free of resistant TB. In this case the
coexistence threshold is given by
R0rðEsÞ
¼ ðS
s þ sLssÞbrðfmþ fsbsI ss þ oÞ
ðmþ fsbsI ss þ oÞðmþ dþ trÞ  ðoþ fsbsI ssÞtr
¼ 1
as derived in Appendix A.4. Resistant strains can invade a
population where sensitive strains are ﬁxed when
R0rðEsÞ41.
The corresponding result for the stability of the
boundary equilibrium is expressed by Theorem 5, stated
below and proved in Appendix A.4.
Theorem 5. Consider system (1) with g ¼ 0. When R0r41,
the equilibrium Er is stable if R0sðErÞo1 and unstable if
R0sðErÞ41. When R0s41, the equilibrium Es is stable for
R0rðEsÞo1 and unstable for R0rðEsÞ41.
Again we emphasise the dependence of the coexistence
threshold on reinfection. Susceptible and latent individuals
infected with sensitive strains are susceptible to (re)infection
with resistant strains at rates brI r (infection) and sbrI rPlease cite this article as: Rodrigues, P., et al., Drug resistance in tube
doi:10.1016/j.tpb.2006.10.004ED
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(superinfection), respectively. The result is the non-linear
curve in Fig. 4(b).
4. Fitness impact on the coexistence region
Drug resistance among M. tuberculosis isolates is caused
by point mutations in the bacterial genome that affect anti-
mycobacterial drug activity. If a mutation that confers drug
resistance can exert a cost to the parasite we may expect
these strains to be less transmissible than the drug sensitive.
To explore the epidemiological consequences of resistance
cost we ﬁx the relative transmission coefﬁcient, a ¼ br=bs,
and explore the system behaviour by varying a parameter b
such that
bs :¼ b; br :¼ ab.
As such, ao1 means that the resistant strains have lower
transmissibility than the sensitive. Despite being less likely,
the possibility a41 is also considered since this topic is still
open to discussion (Cohen et al., 2003; Gagneux et al.,
2006). Fig. 5 shows the bifurcation diagrams obtained for
two values of a. When a ¼ 0:5 (full line) low values of bs
lead to coexistence, but only resistant strains persist for
high rates of transmission, where reinfection prevails. In
this scenario it is possible to induce coexistence of sensitive
and resistant strains by reducing the disease transmission
rate. In turn, coexistence improves the chance of controlling
drug-resistance prevalence. For a ¼ 1:1 (dashed line) bs and
br lie in regions I and II thus, only resistant strains may
persist.
We derive a critical value for a below which a reduction
in the overall transmission can open the possibility for
coexistence:
aC ¼
mðmþ dþ trÞ þ oðmþ dÞ
mðmþ dþ tsÞ þ oðmþ dþ gtsÞ
.
Note that, for the choice of parameters as in Table 1, aC 
0:7745o1 (dotted line in Fig. 5(a)). The critical value aC
will be later used to compare the impact of different control
measures on the coexistence region.
In the case illustrated by a ¼ 0:5, as the transmission
coefﬁcient, b, increases, the system evolves from dominance
of the sensitive strain to dominance of the resistant. This
can be interpreted as follows. The minimal transmissibility
above which resistant strains can be sustained in the
population where sensitive strains are endemic, without the
contribution of acquired resistance (g ¼ 0), is given by the
condition R0rðEsÞ ¼ 1. This marks a threshold in transmis-
sion above which superinfection of sensitive by resistant
strains occurs. This superinfection threshold is marked in
Fig. 6. Below the threshold, resistant strains are out-
competed by the sensitive due to the higher transmission
coefﬁcient of the latter (recall that ao1). In this regime,
resistant cases can only be maintained due to acquired
resistance (g40).
Disease prevalence exhibits a new steep increase, for
sufﬁciently high transmission rates. This is given by therculosis—a reinfection model. Theoretical Population Biology (2006),
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P. Rodrigues et al. / Theoretical Population Biology ] (]]]]) ]]]–]]] 7UNreinfection threshold for the resistant strains, RTr, andmarks the shift in dominance from primary infections toreinfections. Since sensitive strains are no longer circulating
in the population, this threshold is simply R0r ¼ 1=s (with
o ¼ 0, see Gomes et al., 2006, for a derivation).
5. Model extensions—mixed infections
In the model presented in Section 2 we assumed that
active TB resulting from a mixed infection would always
express the resistant phenotype. Now we relax thisPlease cite this article as: Rodrigues, P., et al., Drug resistance in tube
doi:10.1016/j.tpb.2006.10.004D P
ROassumption by also allowing individuals with a mixedinfection to progress to sensitive TB (scenario (ii) in Section2.3). Molecular studies suggest several possible outcomes
for mixed infections (van Rie et al., 2004): sensitive TB may
develop in untreated individuals carrying mixed infections
due to the faster replication of sensitive strains; sensitive
strains may prevail when treatment matches drug regimen
to the resistance pattern speciﬁc to each case; resistant
strains may emerge when treating with ﬁrst line anti-
tuberculosis drugs. Moreover, ﬁtness trade-offs may favour
sensitive strains when competition takes place during the
latent stage but, this will only have impact on transmission
once individuals progress to the disease stage. Although the
possible outcomes we describe here are intuitive and
expected, they are the product of different and complex
mechanisms. These mechanisms are still, quantitatively and
qualitatively, unclear from the molecular point of view.
We extend the two-strain model by introducing a mixed
latent class, Lm, representing the proportion of individuals
with a latent infection that combines both resistant and
sensitive strains—mixed infection. When individuals with
mixed infections progress to active TB, either by endogen-
ous reactivation or exogenous reinfection, a fraction y will
manifest resistant TB entering Imr while the remainder will
develop sensitive TB progressing into Ims. The model is
represented diagrammatically by Fig. 7 and corresponds to
the system of equations:rculosis—a reinfection model. Theoretical Population Biology (2006),
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dS
dt
¼ b ðls þ lr þ mÞS;
dLs
dt
¼ ð1 fÞlsS  ðoþ fsls þ slr þ mÞLs þ ð1 gÞtsI s;
dIs
dt
¼ flsS þ ðoþ fslsÞLs  ðts þ mþ dÞIs;
dLm
dt
¼ ð1 fÞslrLs  ðoþ fsðls þ lrÞ þ mÞLm
þ tsIms þ trImr þ ð1 fÞslsLr;
dIms
dt
¼ ð1 yÞfslrLs þ ð1 yÞðoþ fsðls þ lrÞÞLm
ðts þ mþ dÞIms þ ð1 yÞfslsLr;
dImr
dt
¼ yfslrLs þ yðoþ fsðls þ lrÞÞLm
ðtr þ mþ dÞImr þ yfslsLr;
dLr
dt
¼ ð1 fÞlrS  ðoþ sls þ fslr þ mÞLr þ trI r;
dIr
dt
¼ flrS þ gtsI s þ ðoþ fslrÞLr  ðtr þ mþ dÞI r;
8>>>>>>>>>>>>>>>>>>><
>>>>>>>>>>>>>>>>>>:
(4)
where ls ¼ bsðIs þ ImsÞ and lr ¼ brðIr þ ImrÞ represent the
force of infection of the two types of TB. The parameters
are the same as before with exception of y and the birth
rate, b, that we consider in such a way that the population
size is constant over time, so b ¼ mþ dðIs þ Ims þ I r þ ImrÞ.
Parameter y summarises all mechanisms that determine the
prevailing strain in a mixed infection. It can be varied to
explore different scenarios, depending on the relative
contribution of each mechanism to the overall situation.
Note that with y ¼ 1 we recover the two-strain model
presented in Section 2.
Fig. 8 shows the long-term behaviour of the mixed
infection model when we change parameter y. Notably, the
coexistence region increases as the percentage of mixedPlease cite this article as: Rodrigues, P., et al., Drug resistance in tube
doi:10.1016/j.tpb.2006.10.004infections that progress to sensitive active-TB increases.
The limit case (y ¼ 1) is, in fact, the worst case scenario.
Moreover, coexistence again depends on the transmission
coefﬁcients of both types of strains in a non-linear manner.
A more subtle result is that coexistence is possible for
high transmission levels of drug-resistant strains even when
sensitive strains have low transmissibility. This is related to
the assumption that individuals never succeed in fully
clearing TB bacteria and therefore, mixed infections are
very frequent when either or both strains are highly
transmissible. Under the current assumption, a fraction
yðo1Þ of these infections will progress to resistant TB and
the remaining will progress to sensitive TB, thus forcingrculosis—a reinfection model. Theoretical Population Biology (2006),
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coexistence. In contrast, all mixed infections will develop
into resistant TB when y ¼ 1.
Let us again explore what happens when the transmission
rate of resistant and sensitive strains have a linear
association: br ¼ abs. Parameter a thus expresses the
impact of resistance on pathogen ﬁtness. In Fig. 9(a)
straight lines exemplify two contrasting cases: drug
resistance has an associated cost (a ¼ 0:5, full lines) or
resistant strains have a higher transmission rate (a ¼ 1:1,
dashed lines). When a ¼ 0:5, resistant and sensitive strains
coexist for all possible values of bs. If transmission (bs)
increases, resistant strains start to dominate. But inversely
to the case y ¼ 1 (two-strain model) this does not drive
sensitive strains to extinction because some mixed infec-
tions develop sensitive cases (compare Fig. 9(b) with Fig.
5(b), full lines). Above a certain transmission level, mixed
infections represent almost the totality of TB infections,
and the proportionof resistant TB in the total TB burden is
then driven by y.
6. Control strategies
The World Health Organization (WHO) has two major
control programs for TB: DOTS, Directly Observed
Treatment Short-course, consisting of standardised short-
course treatment of TB cases given under direct obsrvation
to ensure treatment adequacy and compliance; and DOTS-
plus, an extension of DOTS speciﬁcally designed for
controlling multi-drug resistant TB. DOTS-plus uses more
effective, but also more expensive and toxic drugs. It is not
always clear what should be the strategy of choice to
manage resistant TB in a given setting (Dye et al., 2002;
Pablos-Me´ndez et al., 2002): is DOTS enough or should it
be extended to DOTS-plus?
Knowing that reinfection can have strong consequences
on the effectiveness of interventions (Gomes et al., 2004) we
explore how our model behaves under these two strategies.Please cite this article as: Rodrigues, P., et al., Drug resistance in tube
doi:10.1016/j.tpb.2006.10.004D P
RO
OThese control measures are designed to ﬁght different
processes: DOTS prevents the acquisition of resistance due
to treatment failure by ensuring compliance; whereas
DOTS-plus reduces transmission of resistant strains by
adapting the treatment regimen to better suit resistant
cases. Therefore, we model DOTS by reducing the
proportion of failed treatments that leads to acquired
resistance, i.e., lowering g. DOTS-plus is modelled by
reducing the time during which individuals infected with
resistant strains are infectious, i.e., increasing the rate of
recovery from active disease with resistant strains, tr.
We will focus on the case y ¼ 1 which corresponds to the
two-strain TB model (1). However, the mixed-infection
model has similar results as we will discuss.
6.1. Coexistence region
In Section 4 we ﬁxed a ¼ br=bs and described a trend of
strain coexistence at low transmission and dominance of the
resistant strain at high transmission. This trend is veriﬁed
when a is below a critical value, aC . Above this critical
value, resistance is always dominant irrespective of the
transmission intensity. Therefore, the impact of control
strategies on aC gives an indication of its effect on the
extent of the coexistence region. We evaluate the sensitivity
and elasticity of aC to the two parameters, g and tr,
manipulated by DOTS and DOTS-plus, respectively. Using
the terminology from mathematical demography in (Cas-
well, 2001), we introduce the partial derivatives
sp ¼
@aC
@p
and ep ¼
p
aC
@aC
@p
¼ @ ln aC
@ ln p
to deﬁne, respectively, the sensitivity and elasticity of aC to
a parameter p, where p is g or tr. Note that, since equal
increments on a logarithmic scale correspond to equal
proportions on an arithmetic scale, we can say that
elasticity measures proportional sensitivity.rculosis—a reinfection model. Theoretical Population Biology (2006),
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Table 2
Sensitivity and elasticity of aC to g and tr
p Initial value Change 1
3
Sensitivity Elasticity Abs. variation in aC New aC % Variation in aC
(1) (2) (3) (4) ð5Þ  ð2Þ  ð3Þ aC þ ð5Þ ð2Þð1Þ  ð4Þ  100
g 0.003 0.001 0.0098 3:7883 105 9:7797 106 0.7745 0.0013
tr 1.5 0.5 0.4510 0.8735 0.2255 1.0000 29.1157
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Fig. 10. Impact of different control measures on resistant TB (case with a ¼ 0:5): (a) Proportion of resistant TB in total population; (b) Percentage of
resistant phenotype in total TB cases. Full line corresponds to baseline proportion (no intervention), dotted line represents a DOTS like intervention
ðg ¼ 0:0003Þ and dashed line represents a DOTS-plus like intervention ðtr ¼ 2Þ.
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parameter. Both changes increase aC which implies an
improvement on conditions to coexistence. Elasticity is
approximately 3:7883 105 for g and 0.8735 for tr,
corresponding to a variation of approximately 0.001% and
29%, respectively. Thus, for the case of g the improvement
is almost undetectable.
More generally, we can compare the elasticity of aC to
the two parameters g and tr, by looking to the quotient
between absolute value of the elasticities:
etr
eg

 ¼ mtrotsg
1
aC
. (5)
Since the rate of endogenous reactivation of latent TB, o is
several orders of magnitude smaller than the death rate, m,
the rates of recovery under treatment, tr and ts are of the
same order of magnitude and gaC is small, we conclude that
the quotient is greater than one.
These results show that aC is more sensitive to changes in
the infectious period than in the proportion of sensitive TB
treatment failure acquiring resistance. Therefore, the
impact on the coexistence region is greatest for the
DOTS-plus strategy.Please cite this article as: Rodrigues, P., et al., Drug resistance in tube
doi:10.1016/j.tpb.2006.10.004E6.2. Prevalence of infection
A complementary way to assess the effectiveness of the
two control measures is to compare the equilibrium
prevalence of resistant TB before and after the intervention.
Interventions affect both the prevalence of resistant active
TB cases in the population and the percentage of active TB
cases that carry the resistant phenotype (Fig. 10(a) and (b),
respectively).
DOTS-plus like interventions decrease not only the
percentage of resistant TB in the coexistence region but
also the overall prevalence of drug-resistant strains at all
transmission potentials. As the results of the sensitivity
analysis suggest, DOTS-plus can signiﬁcantly increase the
coexistence region which, by itself, inhibits the transmission
of resistance due to strain competition. Moreover, this
control strategy, shifts to the right the superinfection and
reinfection thresholds of resistant strains (R0rðEsÞ ¼ 1 and
R0r ¼ 1=s) delaying the predominance of drug resistance
(see Fig. 10(b)).
We can also observe that a DOTS like intervention has
impact at low transmissibility. In fact, Fig. 10(a) shows that
DOTS is not effective above the superinfection threshold of
resistant strains, R0rðEsÞ ¼ 1. As we have stressed before,
above this threshold the sensitive strains start to decline and
the resistant strains become dominant. Therefore, anyrculosis—a reinfection model. Theoretical Population Biology (2006),
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Is, has negligible impact. Indeed, above the superinfection
threshold, the contribution of acquired drug resistance
through treatment failure (gtsI s) is minimum compared to
cases caused by transmission of resistant strains. When the
transmission potential is below this threshold, on the
contrary, DOTS is the most effective strategy, both in
relative and absolute terms. Moreover, in the limit case
g ¼ 0, system (1) has another equilibrium, Es, correspond-
ing to the presence of only sensitive TB. Below the
superinfection threshold of resistant strains, i.e., for
R0rðEsÞo1, this equilibrium is stable (region IV in Fig. 4
(b)). This means that if acquired drug resistance could be
completely blocked (g ¼ 0) drug-resistant strains would be
eradicated.
The control strategies modelled here have the same
qualitative outcome in the mixed infection model as in the
particular case y ¼ 1. DOTS causes a decrease in resistant
TB prevalence only below the superinfection threshold of
resistant strains, whereas DOTS-plus forces a decrease in
resistant TB prevalence for all endemic scenarios (results
not shown).
Consequently, DOTS-plus may beneﬁt regions of high
endemic prevalence where infection with resistant strains
wipes out the impact of DOTS. By contrast, DOTS is only
effective for low endemic settings and in such scenarios it is,
in fact, more suitable than DOTS-plus.E
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7. Discussion
By using simple models with reinfection we describe how
thresholds in transmission shape the conditions for coex-
istence of resistant and sensitive TB strains and how this
affects resistant TB prevalence and control.
First, we assumed that individuals carrying at least one
resistant strain always manifest and transmit resistant TB.
This simpliﬁcation is justiﬁable by the fact that standard
regimens confer a selection advantage to resistant strains,
while the availability of treatment regimens that are
recommended to combat resistance is limited. However,
other possibilities can and should be considered. In van Rie
et al. (2004), the authors conclude that treatment and
adherence determine which strains are dominant in a mixed
infection with sensitive and resistant strains. They ﬁnd that
treatment with second-line drugs leads to re-emergence of
drug-sensitive strains. Furthermore, within-host competi-
tion may also favour drug-sensitive strains during latency.
We extended the ﬁrst model by implementing two
alternative progressions of mixed infections into active
disease: a proportion y activates resistant TB; while the
remaining ð1 yÞ activates sensitive TB. When y ¼ 1
(original model) coexistence is only observed at low
transmissibility. By contrast, when yo1 (mixed infection
model) coexistence extends to higher transmissibility. APlease cite this article as: Rodrigues, P., et al., Drug resistance in tube
doi:10.1016/j.tpb.2006.10.004D P
RO
OF
reinfection threshold marks the endemic level above which
the majority of individuals harbour mixed infections. The
fact that mixed infections can result in sensitive or resistant
active infections, favours coexistence.
The results obtained are signiﬁcantly different from those
found in models where reinfection is not considered
(Blower and Gerberding, 1998; Dye et al., 2002). For R0
near 1, the system is governed by primary transmission and
coexistence is only possible when resistant strains are
comparatively less transmissible (Austin et al., 1997; Boni
and Feldman, 2005). However, as we move away from
R0 ¼ 1 reinfection starts to play a greater role. When the
majority of individuals harbour mixed infections, the
outcome of within-host competition shapes the frequency
of resistance in the population and may sustain coexistence
in the community.
The mechanisms that determine which phenotype pre-
vails in mixed infections (during latency or active disease)
are still poorly understood. And even if different pathways
have been described (van Rie et al., 2004), little is known
about their frequency in the population. More epidemio-
logical studies are needed to clarify this issue so that
explicit, detailed models can be constructed and used to
explore different interventions.
Reinfection also has implications on the effectiveness of
different control strategies. A DOTS like intervention is
ineffective against resistance in regions where primary
resistance is common—above the superinfection threshold
by resistant strains. It is precisely in those populations that
a switch from DOTS to DOTS-plus can have the greatest
impact. However, DOTS should continue to be the strategy
of choice in populations where superinfection is rare. Even
though DOTS and DOTS-plus interventions are much
more complex than considered here, our work already
highlights fundamental differences in outcome between the
two strategies. Although coexistence results for y ¼ 1 differ
from those obtained with yo1, results concerning inter-
vention efﬁcacy are qualitatively the same.
In conclusion, primary resistance plays a fundamental
role on the outcome of competition between sensitive and
resistant strains in the host population. The strategy of
choice to counteract the spread of resistance depends
critically on the superinfection threshold of resistant
strains.Acknowledgements
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Numeric calculations and some analytical manipulations were obtained using MATLAB 6.5s. Equilibrium curves were
computed with MATCONT continuation package of MATLAB 6.5s (Dhooge et al., 2003).63
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A.1. Calculation of the basic reproduction number for system (1)
In order to compute the basic reproduction number it is important to distinguish new infections from all other class
transitions in population. The infected classes are Ls;Lr; I s and I r. Following van den Driessche and Watmough (2002),
we can write system (1) as
_X ¼ f ðX Þ3 _X ¼FðX Þ VðX Þ ¼FðX Þ  ðVðX Þ VþðX ÞÞ, (6)
where X ¼ ðLs;Lr; Is; Ir;SÞ, F is the rate of appearance of new infections in each class; Vþ is the rate of transfer into
each class by all other means and V is the rate of transfer out of each class. Hence,
F ¼ ðð1 fÞbsI sS; ð1 fÞbrI rS;fbsI sS;fbrI rS; 0ÞT,
and the disease-free equilibrium is X 0 ¼ ð0; 0; 0; 0; 1Þ.
Derivatives DFðX 0Þ and DVðX 0Þ can be partitioned as
DFðX 0Þ ¼
F 0
0 0
 
; DVðX 0Þ ¼
V 0
J3 J4
" #
,
where F and V correspond to the derivatives of F and V with respect to the infected classes:
F ¼
0 0 ð1 fÞbs 0
0 0 0 ð1 fÞbr
0 0 fbs 0
0 0 0 fbr
2
66664
3
77775; V ¼
mþ o 0 ð1 gÞts 0
0 mþ o 0 tr
o 0 mþ dþ ts 0
0 o gts mþ dþ tr
2
66664
3
77775.
The basic reproduction number is deﬁned, following van den Driessche and Watmough (2002), as the spectral radius of
the next generation matrix, FD1:
R0 ¼ maxfR0s;R0rg,
where R0s and R0r are the two eigenvalues:
R0s ¼
bsðoþ fmÞ
ðmþ oÞðmþ dþ tsÞ  ð1 gÞtso
and R0r ¼
brðoþ fmÞ
ðmþ oÞðmþ dþ trÞ  tro
.99OA.2. Disease-free equilibriumC 101
103NProof of Theorem 1. By Theorem 2 in van den Driessche and Watmough (2002) it is sufﬁcient to prove conditions:
105(A1)Plea
doi:1U
if XX0, then F, Vþ, V X0,107(A2) if Xi ¼ 0 then Vi ¼ 0 (where i refers to a vector component),
(A3) Fi ¼ 0 for the components that correspond to uninfected classes,109(A4) if X  is a disease-free equilibrium then FiðX Þ ¼ 0 and Vþi ðX Þ ¼ 0 for the components that correspond to
uninfected classes,111(A5) if F is set to zero then all eigenvalues of Df ðX 0Þ have negative real parts.
113The veriﬁcation of (A1)–(A4) is straightforward.se cite this article as: Rodrigues, P., et al., Drug resistance in tuberculosis—a reinfection model. Theoretical Population Biology (2006),
0.1016/j.tpb.2006.10.004
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The Jacobian of f at X 0 with F set to zero, as
Df ðF¼0ÞðX 0Þ ¼
ðoþ mÞ 0 ð1 gÞts 0 0
0 ðoþ mÞ 0 tr 0
o 0 ðmþ dþ tsÞ 0 0
0 o gts ðmþ dþ trÞ 0
0 0 d bs d br m
2
6666664
3
7777775
.
The eigenvalues are: m and the solutions of equation
p1ðlÞp2ðlÞ ¼ 0,
where p1ðlÞ ¼ l2  a1lþ a0 and p2ðlÞ ¼ l2  b1lþ b0 and
a1 ¼ 2mþ dþ tr þ o,
a0 ¼ mðmþ dþ trÞ þ oðmþ dÞ,
b1 ¼ 2mþ dþ ts þ o,
b0 ¼ mðmþ dþ tsÞ þ oðmþ dþ gtsÞ.
Since a1; a0 and b1; b0 are positive, all eigenvalues have negative real part and the result follows. &
A.3. Boundary and coexistence equilibria O 81
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S;Ls;Lr and Is; Ir:
S ¼ mþ dIs þ dIr
mþ bsI s þ brI r
¼ F ðIs; IrÞ,
Ls ¼ Is
ð1 fÞbsS þ ð1 gÞts
mþ oþ fsbsI s þ sbrI r
¼ I s
ð1 fÞbsF ðIs; IrÞ þ ð1 gÞts
mþ oþ fsbsI s þ sbrI r
¼ GðIs; IrÞIs,
Lr ¼ Ir
ð1 fÞbrðS þ sLsÞ þ tr
mþ oþ fsðbsI s þ brI rÞ
¼ Ir
ð1 fÞbrðF ðIs; IrÞ þ sGðI s; IrÞIsÞ þ tr
mþ oþ fsðbsI s þ brI rÞ
¼ HðIs; I rÞIr.
Suppose that Is ¼ 0 (and subsequently Ls ¼ 0). If I r is non-zero, from the ﬁfth equation of system (1) we get
fbrF ð0; I rÞ þ ðoþ fsbrI rÞHð0; IrÞ  ðmþ dþ trÞ ¼ 0. (7)
We can write this as follows:
PðIrÞ
QðI rÞ
¼ 0,
where P and Q are polynomials of second degree such that
QðI rÞ ¼ ðmþ brI rÞðmþ oþ fsbrI rÞ40,
PðIrÞ ¼ mðp2ðbrÞI2r þ p1ðbrÞIr þ p0ðbrÞÞ,
where
p2ðbrÞ ¼ fsb2ro0,
p1ðbrÞ ¼ fsb2r  ðtr þ oþ mþ ð1 fÞdþ fsðmþ dÞÞbr,
p0ðbrÞ ¼ brðoþ fmÞ  ðmðmþ tr þ dÞ þ oðmþ dÞÞ.
If
br4
mðmþ dþ trÞ þ oðmþ dÞ
fmþ o 3 R0r41,
then p0ðbrÞ40 and we have exactly one positive solution of PðIrÞ.Please cite this article as: Rodrigues, P., et al., Drug resistance in tuberculosis—a reinfection model. Theoretical Population Biology (2006),
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If
brp
mðmþ dþ trÞ þ oðmþ dÞ
fmþ o 3 R0rp1,
then p0ðbrÞp0 but also p1ðbrÞp0, since 0of; so1. So there are no positive solutions of PðIrÞ. &
A.3.1. Calculation of the coexistence threshold when g40
Consider the case only when the sensitive TB is transmissible, in a population where resistant TB is at equilibrium. The
infected compartments are Ls and Is. Following van den Driessche and Watmough (2002), we write system (1) as in (6)
where X ¼ ðLs; I s;S;Lr; IrÞ and
F ¼ ðð1 fÞbsI sS; fbsI sS; 0; 0; 0ÞT.
The disease (sensitive-TB)-free equilibrium is ð0; 0;Sr;Lrr; IrrÞ.
We can compute F and V that correspond to the derivatives at X 0 with respect to the infected classes of F and V,
respectively:
F ¼
0 ð1 fÞbs
0 bs
" #
; V ¼
mþ oþ sbrI rr ð1 gÞts
o mþ dþ ts
" #
.
The basic reproduction number of the sensitive strains in a population where resistant strains are ﬁxed is then the
spectral radius of the next generation matrix, FV1:
R0sðErÞ ¼
Srbsðfðmþ sbrI rrÞ þ oÞ
ðmþ sbrI rrþÞðmþ dþ tsÞ  ð1 gÞtso
.
Remark 4. Note that this is still valid for R0ro1. In this case the disease-free equilibrium is E0 ¼ ð1; 0; 0; 0; 0Þ and we
restore the endemicity threshold.
Proof of Theorem 3. By Theorem 2 in van den Driessche and Watmough (2002) it is sufﬁcient to prove conditions
(A1)–(A5). Once more, conditions (A1)–(A4) are of trivial veriﬁcation. To prove the remaining condition (A5) we write
the Jacobian of f at X 0, with F set to zero, ordering coordinates as ðS;Lr; Ir;Ls; IsÞ. Then, the Jacobian has the form
Df ðF¼0ÞðSr;Lrr; I rr; 0; 0Þ ¼
G1 G2
0 G4
" #
,
where
G1 ¼
ðmþ brI rrÞ 0 d brSr
ð1 fÞbrI rr ðmþ oþ fsbrI rrÞ ð1 fÞbrSr  fsbrLrr þ tr
fbrI
r
r oþ fsbrI rr fbrðSr þ sLrrÞ  ðmþ dþ trÞ
2
64
3
75
and
G4 ¼
ðmþ oþ sbrI rrÞ ð1 gÞts
o ðts þ mþ dÞ
" #
.
Therefore, the eigenvalues of the Jacobian are given by the eigenvalues of G1 and G4.
For G1 the eigenvalues are m and the roots of the polynomial
p1ðlÞ ¼ ðl2  a1lþ a0Þ
where
a1 ¼  ðfSr þ fsLrrÞbr þ ð1þ fsÞI rrbr þ ð2mþ dþ tr þ oÞ,
a0 ¼ fsb2r I rr2 þ ½fsb2r ðSr þ LrrÞ þ brðtr þ oþ mþ ð1 fÞd
þ fsðmþ dÞÞI rr þ mðmþ dþ trÞ þ oðmþ dÞ  brððoþ fmÞSr  fsmLrrÞ.
From equation ﬁve of system (1) at the equilibrium Er we get
ðfSr þ fsLrrÞbrI rr ¼ ðmþ dþ trÞ  oLrr
so a1Irr ¼ oLrr þ ðmþ oÞIrr þ ð1þ fsÞIrr2br40. Since Irr40, a140. From the proof of result 2 we know that Irr is the
only positive solution of PðIrÞ ¼ mðp2ðbrÞI2r þ p1ðbrÞIr þ p0ðbrÞÞ. We can write a0 aslease cite this article as: Rodrigues, P., et al., Drug resistance in tuberculosis—a reinfection model. Theoretical Population Biology (2006),
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a0 ¼  p2ðbrÞIrr2  p1ðbrÞI rr þ fsb2r I rr  fsb2r ðSr þ LrrÞIrr
 p0ðbrÞ þ brðoþ fmÞ  brððoþ fmÞSr  fsmLrrÞ,
Now using the fact that 1 ¼ Sr þ Lrr þ Irr we get
a0 ¼ fsb2r I rrð1 Sr  LrrÞ þ brðoþ fmÞð1 Sr  LrrÞ
þ brðoþ fmÞLrr  brfsmLrr
¼ fsb2r I rr2 þ brðoþ fmÞIrr þ brðoþ fmð1 sÞÞLrr40.
Since a1 and a0 are positive for all possible values of br4
mðmþ dþ trÞ þ oðmþ dÞ
fmþ o all eigenvalues of G1 have negative real
part.
For G4 the characteristic polynomial is
p2ðlÞ ¼ l2  b1lþ b0,
where
b0 ¼ ðmþ sbrI rrÞðmþ dþ tsÞ þ oðmþ dþ gtsÞ,
b1 ¼ 2mþ dþ ts þ oþ sbrI rr.
Since b040 and b140 are both positive we conclude that all eigenvalues of G4 have negative real part. &
Remark 5. From the proof of this result we conclude that stability of Er is equivalent to stability of the endemic
equilibrium of the sub-system with only resistant strains and simultaneously stability of the sensitive TB-free equilibrium.
A.4. Limit case g ¼ 0
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Proof of Theorem 4. To show the existence of Er we just have to repeat the calculations in the proof of result 2 with g ¼ 0.
Suppose now that Ir ¼ 0 (and subsequently Lr ¼ 0). If Ir is non-zero, from the fourth equation of system (1) we get
fbsF ðIs; 0Þ þ ðoþ fsbsI sÞGðIs; 0Þ  ðmþ dþ tsÞ ¼ 0, (8)
where F and G are the same functions as in the proof of result 2. Note that F ðIs; 0Þ;GðI s; 0Þ have the same expression as
F ð0; I rÞ;Hð0; I rÞ, respectively, if we just change the subscripts s; r. Moreover, Eq. (8) will be the same as Eq. (7) if we just
change the subscripts s; r. Therefore, we conclude that for R0s41 we have exactly one positive solution of PðI sÞ, that
corresponds to Es. &
A.4.1. Calculus of the coexistence threshold for g ¼ 0, R0rðEsÞ
Assume g ¼ 0. In what concerns the coexistence threshold for the resistant strains invasion of a population where
sensitive TB is at equilibrium, let us assume that only resistant TB is considered disease. Therefore, the infected
compartments are Lr and Ir and following (van den Driessche and Watmough, 2002), we can write system (1) as in (6) with
X ¼ ðLr; Ir;S;Ls; IsÞ and
F ¼ ðð1 fÞbsI sS;fbsI sS; 0; 0; 0ÞT.
The disease (resistant-TB)-free equilibrium is then X 0 ¼ ð0; 0;Sr;Lrr; I rrÞ. Let us compute F and V corresponding to the
derivatives at X 0, with respect to the infected classes, of F and V, respectively:
F ¼
0 ð1 fÞbrðSs þ sLssÞ
0 fbrðSs þ sLssÞ
" #
; V ¼
mþ oþ fsbsI ss tr
ðoþ fsbsI ssÞ mþ dþ tr
" #
.
The basic reproduction number of the resistant strains, in a population where the sensitive strains are ﬁxed, is the spectral
radius of the next generation matrix, FV1:
R0rðEsÞ ¼
ðSs þ sLssÞbrðfmþ oþ fsbsI ssÞ
ðmþ oþ fsbsI ssÞðmþ dþ trÞ  ðoþ fsbsI ssÞtr
.
Proof of Theorem 5. In what matters the stability of Er we can repeat the calculations in the proof of result 3 with g ¼ 0.
For the case of equilibrium Es ¼ ðSs;Lss; 0; Iss; 0Þ by the Theorem 2 in van den Driessche and Watmough (2002) is
sufﬁcient to prove conditions (A1)–(A5) for the system as we described above. It is straightforward to check (A1)–(A4).
Let us prove condition (A5). For simplicity of calculations let us write the Jacobian of f, withF set to zero, at X 0 with
the following order in the coordinates ðS;Ls; Is;Lr; IrÞ. Then the Jacobian can be written in the following way:Please cite this article as: Rodrigues, P., et al., Drug resistance in tuberculosis—a reinfection model. Theoretical Population Biology (2006),
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Df ðF¼0ÞðS;Lss; Iss; 0; 0Þ ¼
H1 H2
0 H4
" #
,
where
H1 ¼
ðbrI ss þ mÞ 0 d bsSs
ð1 fÞbsI ss ðmþ oþ fsbsI ssÞ ð1 fÞbsSs  fsbsLss þ ts
fbsI
s
s oþ fsbsI ss fbsðSs þ sLssÞ  ðmþ dþ tsÞ
2
64
3
75
and
H4 ¼
ðmþ oþ fsbsI ssÞ tr
oþ fsbsI s ðtr þ mþ dÞ
" #
.
Therefore, the eigenvalues of the Jacobian are given by the eigenvalues of H1 and H4.
Note that H1 is similar to G1 in the proof of result 3 if we just replace the subscript r by s. So we conclude that all
eigenvalues of H1 have negative real part.
For H4 the characteristic polynomial is
p2ðlÞ ¼ l2  b1lþ b0,
where
b0 ¼ ðmþ sbsI ssÞðmþ dþ trÞ þ oðmþ dÞ,
b1 ¼ ð2mþ dþ tr þ oþ sbsI ssÞ.
Since both b040 and b140 all eigenvalues of H4 have negative real parts. &D 87
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